Pensionfund PDN Makes New $3.30 Million Investment in Healthpeak Properties, Inc. $DOC

Pensionfund PDN bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 205,473 shares of the real estate investment trust’s stock, valued at approximately $3,304,000. Healthpeak Properties comprises 2.2% of Pensionfund PDN’s holdings, making the stock its 11th largest holding.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CoreCap Advisors LLC increased its stake in shares of Healthpeak Properties by 22.4% in the 3rd quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock worth $64,000 after acquiring an additional 613 shares during the last quarter. Fiduciary Trust Co boosted its position in shares of Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after acquiring an additional 644 shares during the last quarter. Arjuna Capital grew its holdings in shares of Healthpeak Properties by 4.8% in the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock valued at $283,000 after purchasing an additional 679 shares during the period. Venture Visionary Partners LLC grew its holdings in shares of Healthpeak Properties by 4.8% in the third quarter. Venture Visionary Partners LLC now owns 15,455 shares of the real estate investment trust’s stock valued at $296,000 after purchasing an additional 703 shares during the period. Finally, Quadrant Capital Group LLC increased its position in Healthpeak Properties by 1.9% during the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after purchasing an additional 718 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $17.16 on Tuesday. The stock has a market capitalization of $11.93 billion, a price-to-earnings ratio of 171.59, a price-to-earnings-growth ratio of 9.13 and a beta of 1.11. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The business has a 50-day moving average of $17.27 and a 200 day moving average of $17.54. Healthpeak Properties, Inc. has a 12 month low of $15.71 and a 12 month high of $20.52.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

Analysts Set New Price Targets

Several equities analysts have weighed in on DOC shares. Wells Fargo & Company reiterated a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a report on Monday, January 5th. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their price target for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Healthpeak Properties has an average rating of “Hold” and an average price target of $19.42.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.